Total Freight International (TFI) is proud to announce the expansion of its pharmaceutical logistics services with the addition of a state-of-the-art, temperature-mapped vehicle fleet dedicated exclusively to the safe and compliant transport of medicines, clinical trial samples, and other sensitive healthcare products.
Advanced Temperature Control & Real-Time Monitoring
Each vehicle in TFI’s fleet is qualified through thermal mapping for both hot and cold seasons, ensuring consistent temperature control that accounts for seasonal variations and protects the efficacy of sensitive pharmaceuticals. Every shipment is monitored via GPS, and our deliveries are handled by drivers specialized in pharmaceutical logistics. This approach minimizes risk, safeguards product integrity, and ensures compliance with GDP and regulatory requirements throughout the supply chain.
“Our clients’ trust depends on our ability to deliver their pharmaceutical products safely, securely, and on time,” said Saajin Salim, CEO of TFI. “This dedicated fleet reinforces our commitment to providing GDP-compliant logistics solutions that meet the rigorous demands of the pharmaceutical industry.”
Integrated Cold Chain & Global Reach
The newly introduced fleet seamlessly integrates with TFI’s global network of GDP-certified freight forwarding agents, comprehensive cold chain management solutions, and in-house customs clearance expertise. Supported by a specialized team of pharmaceutical logistics professionals, TFI ensures smooth coordination across local, regional, and international routes, even for complex or time-critical shipments.
Strengthening Healthcare Supply Chains Worldwide
With this latest investment, TFI further strengthens its position as a trusted logistics partner for pharmaceutical and healthcare companies worldwide. By continuously enhancing infrastructure, technology, and expertise, TFI remains focused on meeting the evolving needs of the healthcare industry—delivering compliant, efficient, and innovative logistics solutions that support better patient outcomes across global supply chains.